Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis
- PMID: 34757385
- DOI: 10.1093/bjs/znab376
Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis
Abstract
Background: The exact role of laparoscopic liver resection (LLR) in patients with hepatocellular carcinoma (HCC) and underlying liver cirrhosis (LC) is not well defined. In this meta-analysis, both long- and short-term outcomes following LLR versus open liver resection (OLR) were analysed.
Methods: PubMed, EMBASE, Scopus and Web of Science databases were searched systematically for randomised controlled trials (RCTs) and propensity-score matched (PSM) studies reporting outcomes of LLR versus OLR of HCC in patients with cirrhosis. Primary outcome was overall survival (OS). This was analysed using one-stage (individual participant data meta-analysis) and two-stage (aggregate data meta-analysis) approaches. Secondary outcomes were operation duration, blood loss, blood transfusion, Pringle manoeuvre utilization, overall and major complications, length of hospital stay (LOHS), 90-day mortality and R0 resection rates.
Results: Eleven studies comprising 1618 patients (690 LLR versus 928 OLR) were included for analysis. In the one-stage meta-analysis, an approximately 18.7 per cent lower hazard rate (HR) of death in the LLR group (random effects: HR 0.81, 95 per cent confidence interval [C.I.] 0.68 to 0.96; P = 0.018) was observed. Two-stage meta-analysis resulted in a pooled HR of 0.84 (95 per cent C.I. 0.74 to 0.96; P = 0.01) in the overall LLR cohort. This indicated a 16-26 per cent reduction in the HR of death for patients with HCC and cirrhosis who underwent LLR. For secondary outcomes, LLR was associated with less blood loss (mean difference [MD] -99 ml, 95 per cent C.I. -182 to -16 ml), reduced overall complications (odds ratio 0.49, 95 per cent C.I. 0.37 to 0.66) and major complications (odds ratio 0.45, 95 per cent C.I. 0.26 to 0.79), and shorter LOHS (MD -3.22 days, 95 per cent C.I. -4.38 to -2.06 days).
Conclusion: Laparoscopic resection of HCC in patients with cirrhosis is associated with improved survival and perioperative outcomes.
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Laparoscopic versus open limited liver resection for hepatocellular carcinoma with liver cirrhosis: a propensity score matching study with the Hiroshima Surgical study group of Clinical Oncology (HiSCO).Surg Endosc. 2020 Nov;34(11):5055-5061. doi: 10.1007/s00464-019-07302-y. Epub 2019 Dec 11. Surg Endosc. 2020. PMID: 31828498
-
Meta-analysis of laparoscopic vs open liver resection for hepatocellular carcinoma.World J Gastroenterol. 2012 Dec 7;18(45):6657-68. doi: 10.3748/wjg.v18.i45.6657. World J Gastroenterol. 2012. PMID: 23236242 Free PMC article.
-
Minor laparoscopic liver resection for Hepatocellular Carcinoma is safer than minor open resection, especially for less compensated cirrhotic patients: Propensity score analysis.Surg Oncol. 2018 Dec;27(4):722-729. doi: 10.1016/j.suronc.2018.10.001. Epub 2018 Oct 3. Surg Oncol. 2018. PMID: 30449499
-
Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis.Surg Endosc. 2019 Aug;33(8):2396-2418. doi: 10.1007/s00464-019-06781-3. Epub 2019 May 28. Surg Endosc. 2019. PMID: 31139980
-
A meta-analysis: laparoscopic versus open liver resection for large hepatocellular carcinoma.Minim Invasive Ther Allied Technol. 2025 Feb;34(1):24-34. doi: 10.1080/13645706.2024.2334762. Epub 2024 Apr 18. Minim Invasive Ther Allied Technol. 2025. PMID: 38634257 Review.
Cited by
-
Impact of neoadjuvant chemotherapy on the difficulty and outcomes of laparoscopic and robotic major liver resections for colorectal liver metastases: A propensity-score and coarsened exact-matched controlled study.Eur J Surg Oncol. 2023 Jul;49(7):1209-1216. doi: 10.1016/j.ejso.2023.01.014. Epub 2023 Jan 20. Eur J Surg Oncol. 2023. PMID: 36774216 Free PMC article.
-
Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertension.BJS Open. 2023 Mar 7;7(2):zrad037. doi: 10.1093/bjsopen/zrad037. BJS Open. 2023. PMID: 37115654 Free PMC article. No abstract available.
-
Multilayered insights: a machine learning approach for personalized prognostic assessment in hepatocellular carcinoma.Front Oncol. 2024 Feb 29;13:1327147. doi: 10.3389/fonc.2023.1327147. eCollection 2023. Front Oncol. 2024. PMID: 38486931 Free PMC article.
-
Risk factor analysis of conversion in laparoscopic liver resection for intrahepatic cholangiocarcinoma.Surg Endosc. 2024 Mar;38(3):1191-1199. doi: 10.1007/s00464-023-10579-9. Epub 2023 Dec 11. Surg Endosc. 2024. PMID: 38082010
-
Sub-classification of laparoscopic left hepatectomy based on hierarchic interaction of tumor location and size with perioperative outcomes.J Hepatobiliary Pancreat Sci. 2023 Sep;30(9):1098-1110. doi: 10.1002/jhbp.1323. Epub 2023 Mar 29. J Hepatobiliary Pancreat Sci. 2023. PMID: 36872098 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous